Connection

Charles Bennett to Clinical Trials as Topic

This is a "connection" page, showing publications Charles Bennett has written about Clinical Trials as Topic.
Connection Strength

2.207
  1. Reply to W. Read. J Clin Oncol. 2014 Feb 20; 32(6):604-5.
    View in: PubMed
    Score: 0.329
  2. Finishing the picture: problems with public reporting of clinical trials. J Clin Oncol. 2013 Aug 20; 31(24):2981-2.
    View in: PubMed
    Score: 0.319
  3. Upping recruitment in clinical trials: are the costs worth it? Onkologie. 2009 Jul; 32(7):378-9.
    View in: PubMed
    Score: 0.240
  4. Clinical trials: are they a good buy? J Clin Oncol. 2001 Dec 01; 19(23):4330-9.
    View in: PubMed
    Score: 0.142
  5. Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project. J Clin Oncol. 2000 Aug; 18(15):2805-10.
    View in: PubMed
    Score: 0.130
  6. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA. 1999 Oct 20; 282(15):1453-7.
    View in: PubMed
    Score: 0.123
  7. Economic analyses in clinical trials for cooperative groups: operational considerations. Cancer Invest. 1997; 15(5):448-53.
    View in: PubMed
    Score: 0.101
  8. Interpretation of surrogate endpoints in the era of the 21st Century Cures Act. BMJ. 2016 Dec 30; 355:i6286.
    View in: PubMed
    Score: 0.101
  9. Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry. Leuk Res. 2016 May; 44:61-4.
    View in: PubMed
    Score: 0.096
  10. Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers? Clin Perform Qual Health Care. 1995 Jul-Sep; 3(3):156-64.
    View in: PubMed
    Score: 0.091
  11. Economic analyses of clinical trials in cancer: are they helpful to policy makers? Stem Cells. 1994 Jul; 12(4):424-9.
    View in: PubMed
    Score: 0.085
  12. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy. 2011 Apr; 31(4):408-23.
    View in: PubMed
    Score: 0.068
  13. Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res. 2009 Jun 01; 15(11):3850-5.
    View in: PubMed
    Score: 0.060
  14. Cost considerations in the management of cancer in the older patient. Oncology (Williston Park). 2007 Jun; 21(7):851-7; discussion 858, 860, 862 passim.
    View in: PubMed
    Score: 0.052
  15. Systematic review of piperacillin-induced neutropenia. Drug Saf. 2007; 30(4):295-306.
    View in: PubMed
    Score: 0.051
  16. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol. 2006 Dec; 135(5):642-50.
    View in: PubMed
    Score: 0.050
  17. Reducing adverse drug events in the outpatient chemotherapy setting: attention must be paid. Cancer. 2005 Dec 01; 104(11):2289-91.
    View in: PubMed
    Score: 0.047
  18. Single-arm clinical trials that supported FDA accelerated approvals have modest effect sizes and were at high risk of bias. J Clin Epidemiol. 2022 08; 148:193-195.
    View in: PubMed
    Score: 0.036
  19. Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making. Leuk Lymphoma. 2000 Mar; 37(1-2):65-70.
    View in: PubMed
    Score: 0.032
  20. Comparing cost-effectiveness analyses for the clinical oncology setting: the example of the Gynecologic Oncology Group 111 trial. Cancer Invest. 2000; 18(3):261-8.
    View in: PubMed
    Score: 0.031
  21. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol. 2008 Jan 01; 26(1):132-49.
    View in: PubMed
    Score: 0.013
  22. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood. 2002 Oct 01; 100(7):2303-20.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.